EC Healthcare Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-5.00
11.00
123.00
322.00
260.00
360.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
119.00
-47.00
-168.00
-134.00
80.00
13.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
706.00
645.00
608.00
603.00
616.00
574.00
Cash Flow from Investing Activities
292.00
-512.00
-715.00
-586.00
-366.00
314.00
Cash Flow from Financing Activities
-548.00
-289.00
-51.00
-80.00
158.00
-735.00
Net Cash Inflow / Outflow
450.00
-156.00
-160.00
-60.00
410.00
153.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
-1.00
1.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EC Healthcare
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-5.709
27.6444553123353
-32.00
-120.65%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
119.413
18.8936846794821
101.00
532.03%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
706.212
59.2821070366144
647.00
1091.27%
Cash Flow from Investing Activities
292.746
-343.373690921151
635.00
185.26%
Cash Flow from Financing Activities
-548.224
-4.79552205539706
-544.00
-11332.00%
Net Cash Inflow / Outflow
450.288
-283.83353861002
733.00
258.65%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.446
5.05356732991312
-5.00
-108.83%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 9.34% vs 6.18% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
706.21
645.89
9.34%






